Isshaan Biomed Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 17 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.00 Cr
as on 24-10-2024
- Revenue %
(FY 2023)
- Profit 16.68%
(FY 2023)
- Ebitda -45.72%
(FY 2023)
- Net Worth -25.21%
(FY 2023)
- Total Assets 10.78%
(FY 2023)
About Isshaan Biomed
The Corporate was formerly known as Biotavia Healthcare Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹20.00 Cr.
Ashutosh Gupta, Sanjay Singh, and Rahul Singh serve as directors at the Company.
- CIN/LLPIN
U74120DL2007PTC165026
- Company No.
165026
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jun 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Isshaan Biomed?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashutosh Gupta  | Additional Director | 19-Jan-2024 | Current |
| Sanjay Singh | Director | 22-Oct-2020 | Current |
| Rahul Singh | Director | 11-May-2015 | Current |
Financial Performance of Isshaan Biomed.
Isshaan Biomed Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 16.68% increase in profit. The company's net worth observed a substantial decline by a decrease of 25.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Isshaan Biomed?
In 2023, Isshaan Biomed had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sunrise Structures & Developers Private LimitedActive 12 years 5 monthsAshutosh Gupta is a mutual person
Isshaan Healthcare Private LimitedActive 17 years 2 monthsAshutosh Gupta, Sanjay Singh and 1 more are mutual person
- Isshaan Medicare Private LimitedActive 2 years 6 months
Ashutosh Gupta and Sanjay Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 18 Jun 2024 | ₹20.00 Cr | Open |
How Many Employees Work at Isshaan Biomed?
Unlock and access historical data on people associated with Isshaan Biomed, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Isshaan Biomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Isshaan Biomed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
